SLE stands for systemic lupus erythematosus, an autoimmune disease in which the immune system attacks the body’s own healthy tissues. Each word in the name describes a key feature of the condition: “systemic” means it can affect virtually any organ, “lupus” refers to the wolf-like facial rash historically associated with the disease, and “erythematosus” means reddened, pointing to the characteristic skin inflammation. SLE is the most common and most serious form of lupus.
How SLE Affects the Body
In a healthy immune system, antibodies target foreign invaders like bacteria and viruses. In SLE, the body produces autoantibodies that mistakenly attack its own cells, particularly the proteins and genetic material inside cell nuclei. These are called antinuclear antibodies, or ANAs, and nearly everyone with SLE tests positive for them.
The damage happens through a chain reaction. Autoantibodies bind to fragments of the body’s own DNA and RNA, forming clumps called immune complexes. These complexes settle in tissues throughout the body, triggering inflammation wherever they land. They also activate a branch of the immune system’s alarm network (type I interferon), which ramps up inflammation even further. This is why SLE can affect so many different organs at once: the kidneys, heart, lungs, skin, joints, and brain are all potential targets.
Who Gets SLE
An estimated 204,000 people in the United States have SLE. The disease is overwhelmingly more common in women: roughly 9 out of every 10 people with SLE are female, and women of childbearing age (15 to 44) face the highest risk. Men can develop SLE, but they account for only about 20,000 of the U.S. cases. Black, Hispanic, and Asian women are diagnosed more frequently and often experience more severe disease than white women.
Common Symptoms
The most common symptom is fatigue, often described as an exhaustion that sleep doesn’t fix. Joint and muscle pain or swelling affect most people with the disease at some point, particularly in the hands, wrists, and knees. Many people experience a butterfly-shaped rash across the cheeks and nose, which is one of the most recognizable signs of SLE. Other frequent symptoms include unexplained fevers, hair loss, and recurring mouth sores.
Because SLE is systemic, it can also cause symptoms that seem unrelated to each other. Fluid can build up around the lungs or heart, leading to chest pain and shortness of breath. Kidney involvement, called lupus nephritis, may show no obvious symptoms early on but can progress to serious damage if untreated. Some people develop neurological symptoms including seizures, confusion, or psychosis.
How SLE Is Diagnosed
There is no single test that confirms SLE. Doctors use a combination of blood work, symptoms, and physical findings. The first step is usually an ANA blood test. A positive ANA result at a certain threshold is considered a requirement before SLE can even be considered, though a positive ANA alone doesn’t mean you have lupus since many healthy people test positive too.
If the ANA is positive, doctors look for more specific antibodies. Anti-double-stranded DNA (anti-dsDNA) antibodies and anti-Smith antibodies are much more closely tied to SLE and carry significant weight in diagnosis. Complement proteins (C3 and C4), which get consumed during immune complex reactions, are also measured. Low levels suggest active disease.
The current classification system uses a point-based approach across multiple domains: skin findings, joint involvement, kidney function, blood cell counts, neurological symptoms, and immune markers. Each finding is assigned a weighted score. A total of 10 or more points, with at least one clinical symptom present, meets the threshold for an SLE classification. For example, the butterfly rash alone is worth 6 points, and severe kidney involvement confirmed by biopsy scores a full 10.
Triggers and Flares
SLE tends to follow a pattern of flares and remissions. Certain triggers are well established. Ultraviolet light is one of the most consistent: most people with SLE are photosensitive, and even modest sun exposure (particularly UVB wavelengths) can worsen skin disease and set off a systemic flare. UV exposure activates molecular alarm signals in the skin that spread inflammation both locally and throughout the body.
Infections are another common trigger, as they rev up the same immune pathways that are already overactive in SLE. Hormonal shifts, emotional stress, and certain medications can also provoke flares. Wearing sunscreen daily, avoiding peak sun hours, and managing stress are practical steps that make a real difference in flare frequency.
Treatment Approaches
The cornerstone of SLE treatment is hydroxychloroquine, an antimalarial drug that has become one of the most important medications in lupus care. It reduces flare frequency, slows long-term organ damage, and has even been shown to improve survival. It is recommended for essentially all SLE patients unless they cannot tolerate it. Most people take it daily as a long-term medication.
For flares and more active disease, doctors add anti-inflammatory medications (corticosteroids) at varying doses depending on severity. The goal is to use the lowest effective dose and taper off as quickly as possible, since long-term steroid use carries its own risks. When steroids and hydroxychloroquine aren’t enough, stronger immune-suppressing drugs are brought in to control specific problems like kidney inflammation or severe blood cell abnormalities.
Newer biologic therapies target specific parts of the immune system. One blocks a protein that keeps overactive immune cells alive, while another directly shuts down the type I interferon signaling that drives so much of the disease. These are typically reserved for moderate-to-severe SLE that hasn’t responded well to standard treatment.
Long-Term Outlook
SLE is a chronic condition with no cure, but outcomes have improved dramatically over the past several decades. Current data show a five-year survival rate of about 91% and an eight-year survival rate of 89%. Most people with SLE live full lives, though the disease requires ongoing monitoring and medication adjustments. The biggest threats to long-term health are kidney damage, cardiovascular disease, and complications from the medications themselves. Regular blood and urine testing allows doctors to catch organ involvement early, when treatment is most effective.
Anti-dsDNA antibody levels and complement protein levels are the two markers most commonly tracked over time. Rising anti-dsDNA and falling complement levels often signal an approaching flare before symptoms appear, giving doctors a window to adjust treatment proactively.